Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ADMA Biologics

Request full access

ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics

Ramsey, United StatesFounded 2004Biotech & Life Sciences

About ADMA Biologics

ADMA Biologics, accessible at admabiologics.com, is a biopharmaceutical company dedicated to improving the lives of immunocompromised patients and those at risk for certain infections. The company specializes in developing and manufacturing plasma-derived therapeutics, which are medications made from human plasma to treat and prevent diseases. ADMA operates in the healthcare and biotechnology market, focusing on providing innovative solutions for immune-compromised individuals.

ADMA Biologics serves a specific clientele, primarily authorized U.S. healthcare providers who are trained to prescribe or supply medicinal products. These healthcare providers rely on ADMA's products to treat patients with immune deficiencies and other related conditions. The company's business model is multifaceted, encompassing both the collection of human plasma through its subsidiary, ADMA BioCenters, and the production of plasma-derived therapies.

ADMA Biologics generates revenue through several streams. Firstly, it collects human plasma, which is then processed into specialized medications. Secondly, the company offers contract manufacturing services, providing a full suite of Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) opportunities. This means that ADMA not only produces its own products but also manufactures products for other companies, leveraging its expertise and facilities.

The company is led by Mr. Grossman, who has been with ADMA Biologics since its early days and has played a crucial role in its development and growth. Under his leadership, ADMA has secured several patents that form the basis of its manufacturing methods and product compositions.

In summary, ADMA Biologics is a pioneering biopharmaceutical company focused on plasma-derived therapies, serving healthcare providers and patients with immune deficiencies. It operates through plasma collection, product manufacturing, and contract services, ensuring a diversified revenue stream.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2013
Outcome tier
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

ADMA Biologics in the Ramsey ecosystem

Live from Dealroom

The ADMA Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later7 investors entered at this stage

  • Biomark Capital
  • Hercules Capital
  • Oxford Finance
  • Marathon Asset Management
  • Perceptive Advisors
  • Hayfin Capital Management
  • Ares Management
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States99.6%
🏳️ Rwanda0.4%
2 countries shown
Web traffic by country
17K monthly visits
across markets
🇺🇸 United States58.2%
🇦🇺 Australia10.6%
🇬🇧 United Kingdom7.1%
🇨🇦 Canada6.5%
🇮🇳 India5.9%
Top 5 markets shown

Patents

Estimated portfolio value
$22M

5 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ADMA Biologics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ADMA Biologics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.